Indian patent office begins data compilation on 'working patents'

14 January 2010

In what is perceived as likely to be an enormous task, the Indian government - for the first time - has started the process of compiling data on the status of the valid patents granted during the last over 20 years in the country.

Aiming to codify a data to make it available to the public, the Controller General of Patents, Designs and Trademarks has asked patentees and licensees to provide information 'on working of patents' before March 31, 2010, reports the PharmaBoz.com news service. The Controller General of Patents has also warned that any failure to comply with the order will attract punishment.

In a notification dated December 24, 2009, the Controller General of Patents said: 'All patentees and licensees are required to furnish information in Form No 27 on working of patents as prescribed under section 146 of the Patents Act (as amended) read with Rule 131 of the Patents Rule 2003 (as amended). Attention of the patentees/licensees are also invited to provisions of section 122 of the Patents Act, 1970 (as amended) wherein penalty is prescribed for non-submission of such information.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical